Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR

Journal of Medical Microbiology

Volumn 60, Issue 10, 2011, Pages 1447-1454

  Bang, Hyeeun ^a   Park, Sangjung ^a   Hwang, Joohwan ^a   Jin, Hyunwoo ^a   Cho, Eunjin ^b   Kim, Dae Yoon ^c   Song, Taeksun ^b   Shamputa, Isdore Chola ^d   Via, Laura E ^d   Barry III, Clifton E ^d   Cho, Sang Nae ^e   Lee, Hyeyoung ^a  

^a Yonsei University Wonju   (South Korea)

^b International Tuberculosis Research Center   (South Korea)

^c National Mokpo Tuberculosis Hospital   (South Korea)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AHPC PROTEIN; BACTERIAL PROTEIN; ISONIAZID; KATG PROTEIN; OXYR PROTEIN; PROTEIN INHA; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE LOCUS; GENE MUTATION; HUMAN; INTERGENERIC HYBRIDIZATION; MOLECULAR DIAGNOSIS; MOLECULAR HYBRIDIZATION; MOLECULAR PROBE; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE HYBRIDIZATION ASSAY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID HYBRIDIZATION; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 80053165969     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.032292-0     Document Type: Article

References (22)

1. American Thoracic Society & Centers for Disease Control and Prevention (2000). Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 161, 1376-1395.
2. Barry, C. E., III, Slayden, R. A. & Mdluli, K. (1998). Mechanisms of isoniazid resistance in Mycobacterium tuberculosis. Drug Resist Updat 1, 128-134.
3. Bártfai, Z., Somoskövi, A., Ködmön, C., Szabó, N., Puskás, E., Kosztolányi, L., Faragó, E., Mester, J., Parsons, L. M. & Salfinger, M. (2001). Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol 39, 3736-3739.
4. Cavusoglu, C., Hilmioglu, S., Guneri, S. & Bilgic, A. (2002). Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol 40, 4435-4438.
5. Cirillo, D. M., Piana, F., Frisicale, L., Quaranta, M., Riccabone, A., Penati, V., Vaccarino, P. & Marchiaro, G. (2004). Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB). New Microbiol 27, 221-227.
6. Edwards, K. J., Metherell, L. A., Yates, M. & Saunders, N. A. (2001). Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe analysis. J Clin Microbiol 39, 3350-3352.
7. El-Hajj, H. H., Marras, S. A., Tyagi, S., Kramer, F. R. & Alland, D. (2001). Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol 39, 4131-4137.
8. Herrera, L., Jiménez, S., Valverde, A., García-Aranda, M. A. & Sáez-Nieto, J. A. (2003). Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). Description of new mutations in the rpoB gene and review of the literature. Int J Antimicrob Agents 21, 403-408.
9. Herrera-León, L., Molina, T., Saíz, P., Sáez-Nieto, J. A. & Jiménez, M. S. (2005). New multiplex PCR for rapid detection of isoniazid-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob Agents Chemother 49, 144-147.
10. Hillemann, D., Rüsch-Gerdes, S. & Richter, E. (2007). Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 45, 2635-2640.
11. Mäkinen, J., Marttila, H. J., Marjamäki, M., Viljanen, M. K. & Soini, H. (2006). Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 44, 350-352.
12. Mani, C., Selvakumar, N., Narayanan, S. & Narayanan, P. R. (2001). Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol 39, 2987-2990.
13. Mokrousov, I., Narvskaya, O., Otten, T., Limeschenko, E., Steklova, L. & Vyshnevskiy, B. (2002). High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother 46, 1417-1424.
14. Musser, J. M. (1995). Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 8, 496-514.
15. Musser, J. M., Kapur, V., Williams, D. L., Kreiswirth, B. N., van Soolingen, D. & van Embden, J. D. (1996). Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and-susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J Infect Dis 173, 196-202.
16. Piatek, A. S., Telenti, A., Murray, M. R., El-Hajj, H., Jacobs, W. R., Jr, Kramer, F. R. & Alland, D. (2000). Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother 44, 103-110.
17. Raviglione, M. C., Snider, D. E., Jr & Kochi, A. (1995). Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273, 220-226.
18. Slayden, R. A. & Barry, C. E., III (2000). The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect 2, 659-669.
19. Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J. & Cole, S. (1993). Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341, 647-651.
20. Telenti, A., Honoré, N., Bernasconi, C., March, J., Ortega, A., Heym, B., Takiff, H. E. & Cole, S. T. (1997). Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 35, 719-723.
21. van Doorn, H. R., Claas, E. C., Templeton, K. E., van der Zanden, A. G., te Koppele Vije, A., de Jong, M. D., Dankert, J. & Kuijper, E. J. (2003). Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 39-minor groove binder-DNA probes. J Clin Microbiol 41, 4630-4635.
22. Yue, J., Shi, W., Xie, J., Li, Y., Zeng, E. & Wang, H. (2003). Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China. J Clin Microbiol 41, 2209-2212.